0000899243-20-004906.txt : 20200218
0000899243-20-004906.hdr.sgml : 20200218
20200218165845
ACCESSION NUMBER: 0000899243-20-004906
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200214
FILED AS OF DATE: 20200218
DATE AS OF CHANGE: 20200218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Raythatha Jigar
CENTRAL INDEX KEY: 0001745787
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38584
FILM NUMBER: 20626127
MAIL ADDRESS:
STREET 1: 215 FIRST STREET, SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001434418
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-714-0555
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-14
0
0001434418
CONSTELLATION PHARMACEUTICALS INC
CNST
0001745787
Raythatha Jigar
C/O CONSTELLATION PHARMACEUTICALS, INC.
215 FIRST STREET, SUITE 200
CAMBRIDGE
MA
02142
1
1
1
0
President and CEO
Stock Option (right to buy)
36.06
2020-02-14
4
A
0
200000
0.00
A
2030-02-13
Common Stock
200000
200000
D
This option was granted on February 14, 2020, and the shares underlying the option vest in equal quarterly installments through February 14, 2024, subject to continued service.
/s/ Karen Valentine, as attorney-in-fact
2020-02-18